Output details
1 - Clinical Medicine
University of Plymouth
Return to search
Output 0 of 0 in the submission
Article title
Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial
Type
D - Journal article
Title of journal
LANCET ONCOLOGY
Article number
-
Volume number
12
Issue number
8
First page of article
773
ISSN of journal
1470-2045
Year of publication
2011
Number of additional authors
19
Additional information
The author made a substantial contribution to the conception and design of the study and carrying out the study (including acquisition of study). The author helped draft the output.
Interdisciplinary
-
Cross-referral requested
-
Research group
None
Citation count
22
Proposed double-weighted
No
Double-weighted statement
-
Reserve for a double-weighted output
No
Non-English
No
English abstract
-